Healthcare -
Biotechnology - NASDAQ - US
$ 3.6301
4.61 %
$ 2.65 B
Market Cap
-4.03
P/E
IBRX - CASH FROM OPERATIONS
Cash from Operations IBRX - ImmunityBio, Inc.
-367 M
LAST VALUE
-15.61%
2 YEAR CAGR
-42.06%
5 YEAR CAGR
-87.91%
10 YEAR CAGR